426
Views
0
CrossRef citations to date
0
Altmetric
Foreword

Celebrating the Collaboration Between Bioanalysis Zone and Bioanalysis

Page 381 | Received 16 Feb 2022, Accepted 17 Feb 2022, Published online: 21 Mar 2022

“The relationship between Bioanalysis and Bioanalysis Zone has enabled both to be at the forefront of significant developments, reporting on the latest news and emerging trends over the last 10 years.”

In honor of Bioanalysis Zone turning 10 in 2021, we are excited to present this special feature in Bioanalysis focused on updates from the authors of key articles published in the journal over the last 10 years. In addition to contributions to large molecule bioanalysis by liquid chromatography–mass spectrometry (LC–MS) and the role of biomarkers in drug development, this feature also includes updates from previous Bioanalysis Rising Star Award and Bioanalysis Outstanding Contribution Award winners on their current projects.

The relationship between Bioanalysis and Bioanalysis Zone has enabled both to be at the forefront of significant developments, reporting on the latest news and emerging trends over the last 10 years. Thus, to celebrate this collaboration, we review some of the articles that have been influential in furthering discussions over the last 10 years and present updates from the authors who wrote them. While putting together these updates, we also reflected on how far the industry has come and where it is projected to go – especially after the global COVID-19 pandemic. In this feature, we explore how mass spectrometry imaging developed into what it is today and how LC–MS is used for large molecule bioanalysis, and reflect on the next steps for capillary electrophoresis mass spectrometry for metabolomics.

We hope you enjoy this feature and would like to thank you for all your support and contributions to both Bioanalysis and Bioanalysis Zone over the past decade.

Financial & competing interests disclosure

A White is an employee of Future Science Group. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.